AG

Alrov Group

Asia, Tel Aviv, Israel, Tel Aviv-yafo

Description

Alrov Group is a real estate company that offers property development services.

Investor Profile

Alrov Group has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in Israel.
  • Strong thematic focus on Biotechnology, Manufacturing, Pharmaceutical.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • Israel (100%)

Industry Focus

  • Biotechnology
  • Manufacturing
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Alrov Group frequently co-invest with?

Rosalind Capital Partners
North America, Ontario, Canada, Toronto
Co-Investments: 1
Psagot Investment House
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 1
Highbridge Capital Management
North America, New York, United States, New York
Co-Investments: 1
UO
North America, Illinois, United States, Chicago
Co-Investments: 1
More Investment House
Asia, Tel Aviv, Israel, Ramat Gan
Co-Investments: 1

What are some of recent deals done by Alrov Group?

Protalix BioTherapeutics

Carmiel, HaZafon, Israel

Protalix is a biopharmaceutical company that is revolutionizing the development and manufacturing of recombinant therapeutic proteins.

BiotechnologyManufacturingPharmaceuticalTherapeutics
Post Ipo EquityMar 12, 2020
Amount Raised: $43,700,000